Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/14/07 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
24 | |
| 04/12/07 | 1-E | Notification under Regulation E by small business investment companies and business development companies. |
|
1 | |
| 04/02/07 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
46 | |
| 01/16/07 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/12/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/06 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
26 | |
| 10/24/06 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
26 | |
| 10/23/06 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
15 | |
| 10/20/06 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
38 | |
| 10/10/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
